Adults with Von Hippel-Lindau disease to benefit from new treatment
NICE has recommended belzutifan for some adults with Von Hippel-Lindau disease, in final draft guidance, which could benefit up to 100 people.
News, blogs and podcasts
Latest articles
Emergency kits for people with adrenal insufficiency recommended to avoid hospital admission
People with adrenal insufficiency should be given an emergency medical kit with potentially life-saving steroid injections, according to our new clinical guideline.
Benefits of new Alzheimer’s treatment lecanemab are too small to justify the cost to the NHS
Our draft recommendation follows analysis of clinical trial evidence and reviewing the benefits of slowing disease progression, with the cost of treatment.
Thousands could benefit from new option for treating symptoms of uterine fibroids
As many as 30,000 adults could benefit from a new treatment for moderate to severe symptoms of uterine fibroids after we published final guidance today (14 August 2024) recommending linzagolix.
Latest in-depth
NICE annual report and accounts 2023/24
Our annual report and accounts, which summarises our key achievements from April 2023 to March 2024.
Implementing an antimicrobial prescribing strategy for ear infection in children
We explore how North East and North Cumbria Integrated Care Board used behaviour change techniques to implement our antimicrobial prescribing guideline on acute otitis media.
Latest blogs
Introducing a new way of prioritising our guidance topics
NICE's deputy chief executive, Jonathan Benger, talks about our new approach to prioritisation.
How NICE is ensuring its topic prioritisation decisions are grounded in lived experience
Simon Denegri discusses NICE’s commitment to involving the public voice in its work and decisions.
Latest podcasts
Learn more about NICE's new guideline on identifying and managing adrenal insufficiency
Learn more about the NICE and NHS England MedTech Pathway consultation
